Inhibition of Calcium Uptake via the Sarco/Endoplasmic Reticulum Ca2+-ATPase in a Mouse Model of Sandhoff Disease and Prevention by Treatment with N-Butyldeoxynojirimycin
Open Access
- 1 August 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (32) , 29496-29501
- https://doi.org/10.1074/jbc.m302964200
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Glycosphingolipid lysosomal storage diseases: therapy and pathogenesisNeuropathology and Applied Neurobiology, 2002
- Lysosomal storage results in impaired survival but normal neurite outgrowth in dorsal root ganglion neurones from a mouse model of Sandhoff diseaseNeuropathology and Applied Neurobiology, 2002
- Depletion of intracellular calcium stores is toxic to SH-SY5Y neuronal cellsBrain Research, 2001
- Biochemical consequences of mutations causing the GM2 gangliosidosesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1999
- Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N -butyldeoxynojirimycinProceedings of the National Academy of Sciences, 1999
- Glycosphingolipid degradation and animal models of GM2‐gangliosidosesJournal of Inherited Metabolic Disease, 1998
- Bcl‐2 Protects Against Apoptosis in Neuronal Cell Line Caused by Thapsigargin‐Induced Depletion of Intracellular Calcium StoresJournal of Neurochemistry, 1998
- Prevention of Lysosomal Storage in Tay-Sachs Mice Treated with N -ButyldeoxynojirimycinScience, 1997
- Mice lacking both subunits of lysosomal β–hexosaminidase display gangliosidosis and mucopolysaccharidosisNature Genetics, 1996
- Mouse models of Tay–Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolismNature Genetics, 1995